NEWS
July 16, 2024
Targretin® (Bexarotene) receives Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma
July 5, 2023
Renewal: Message from CEO & President
March 30, 2011
![BackNumber](common/img/btn_backnumber_off.gif)
July 16, 2024
Targretin® (Bexarotene) receives Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma
July 5, 2023
Renewal: Message from CEO & President
March 30, 2011